New Product

Woollen liners that are completely compostable and biodegradable! Made using natural and responsible materials, our new Woolcool thermal insulated mailing pouches help keep our products [...]

Ashtons has recently produced a new handy antipsychotic dosage and percentage calculator. The guide offers an easy way to calculate the percentage BNF values of each antipsychotic. The chart is [...]

Asthma is a long-term condition characterised by paroxysmal and reversible obstruction of the airways, whereas Chronic Obstructive Pulmonary Disease (COPD) is a chronic, not fully reversible [...]

High Dose Antipsychotic Treatment (HDAT) is a term many of us are familiar with but are you confident in it’s use, need and subsequent monitoring requirements? Are the multidisciplinary team [...]

Advance planning for flu vaccination clinics has become an important part of patient care. The flu vaccination delivered in the following year provides vulnerable patients with protection against [...]

Cariprazine (Reagila) is a new second-generation antipsychotic which is licensed to treat schizophrenia in adults (over 18 years). It is only available as an oral capsule and is presented in [...]

A new formulation of clozapine will be available from June 2019 consisting of an oral dispersible tablet marketed as Zaponex orodispersible tablets by the company Leyden Delta BV. The special [...]

The British Standards Institute (BSI) has undertaken a review of the contents of first aid kits and updated them to a new British standard specification (BS 8599–1:2019). The standard has been [...]

Buprenorphine has been long-established as an opioid substitution medication available as sublingual tablets. It is an opioid partial agonist/antagonist with strong receptor binding affinity and [...]

Nyxoid (naloxone nasal spray) is a novel formulation of naloxone, which is used for the emergency treatment of a patient who has a suspected opioid overdose. The single-use spray is administered [...]